|
DE19624659A1
(de)
|
1996-06-20 |
1998-01-08 |
Klinge Co Chem Pharm Fab |
Neue Pyridylalken- und Pyridylalkinsäureamide
|
|
US6451816B1
(en)
|
1997-06-20 |
2002-09-17 |
Klinge Pharma Gmbh |
Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression
|
|
JPH10338658A
(ja)
*
|
1997-04-08 |
1998-12-22 |
Hoechst Marion Roussel Kk |
レチノイド作用調節剤
|
|
US6903118B1
(en)
|
1997-12-17 |
2005-06-07 |
Klinge Pharma Gmbh |
Piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides
|
|
DE19756212A1
(de)
|
1997-12-17 |
1999-07-01 |
Klinge Co Chem Pharm Fab |
Neue, mit einem cyclischen Imid substituierte Pyridylalkan-, alken- und -alkincarbonsäureamide
|
|
DE19756261A1
(de)
|
1997-12-17 |
1999-07-01 |
Klinge Co Chem Pharm Fab |
Neue arylsubstituierte Pyridylalkan-, alken- und alkincarbonsäureamide
|
|
DE19756235A1
(de)
|
1997-12-17 |
1999-07-01 |
Klinge Co Chem Pharm Fab |
Neue piperidinylsubstituierte Pyridylalkan- alken- und -alkincarbonsäureamide
|
|
DE19818044A1
(de)
*
|
1998-04-22 |
1999-10-28 |
Klinge Co Chem Pharm Fab |
Verwendung von Vitamin-PP-Verbindungen
|
|
US6291459B1
(en)
*
|
1998-08-12 |
2001-09-18 |
Smithkline Beecham Corporation |
Calcilytic compounds
|
|
EP1031564A1
(en)
*
|
1999-02-26 |
2000-08-30 |
Klinge Pharma GmbH |
Inhibitors of cellular nicotinamide mononucleotide formation and their use in cancer therapy
|
|
DE19908483A1
(de)
*
|
1999-02-26 |
2000-10-05 |
Klinge Co Chem Pharm Fab |
Inhibitoren der zellulären Niacinamidmononucleotid-Bildung
|
|
WO2002013802A2
(en)
|
2000-08-11 |
2002-02-21 |
Wyeth |
Method of treating estrogen receptor positive carcinoma
|
|
ES2527688T3
(es)
|
2000-09-29 |
2015-01-28 |
Glaxo Group Limited |
Derivados de morfolin-acetamida para el tratamiento de enfermedades inflamatorias
|
|
EP1348434A1
(en)
*
|
2002-03-27 |
2003-10-01 |
Fujisawa Deutschland GmbH |
Use of pyridyl amides as inhibitors of angiogenesis
|
|
GB0207445D0
(en)
*
|
2002-03-28 |
2002-05-08 |
Glaxo Group Ltd |
Novel compounds
|
|
US7977049B2
(en)
|
2002-08-09 |
2011-07-12 |
President And Fellows Of Harvard College |
Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
|
|
CA2601508C
(en)
|
2005-03-17 |
2012-01-03 |
Pfizer, Inc. |
Cyclopropanecarboxamide derivatives
|
|
PE20071159A1
(es)
|
2005-10-31 |
2007-11-30 |
Schering Corp |
Derivados de tropano 3-monosustituido como ligandos de receptores de nociceptina
|
|
WO2007053499A2
(en)
|
2005-11-01 |
2007-05-10 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as antagonists of ccr2
|
|
WO2007053498A1
(en)
|
2005-11-01 |
2007-05-10 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as antagonists of ccr2
|
|
HUP0600809A3
(en)
*
|
2006-10-27 |
2008-09-29 |
Richter Gedeon Nyrt |
New phenylsulfamoyl-benzamide derivatives as bradykinin antagonists, process and intermediates for their preparation and pharmaceutical compositions containing them
|
|
EP2098231A1
(en)
|
2008-03-05 |
2009-09-09 |
Topotarget Switzerland SA |
Use of NAD formation inhibitors for the treatment of ischemia-reperfusion injury
|
|
RU2529468C2
(ru)
|
2008-06-24 |
2014-09-27 |
Топотаргет А/С |
Производные 1, 2-дигидроциклобутендиона в качестве ингибиторов фосфорибозилтрансферазы никотинамида
|
|
AU2009286604B2
(en)
|
2008-08-29 |
2015-05-28 |
Onxeo Dk, Branch Of Onxeo S.A., France |
Novel urea and thiourea derivatives
|
|
JP2012533530A
(ja)
|
2009-07-17 |
2012-12-27 |
トポターゲット・アクティーゼルスカブ |
ニコチンアミドホスホリボシルトランスフェラーゼ阻害剤による癌治療の副作用の重症度を低下させるためのニコチン酸またはその前駆体もしくはプロドラッグ投与の有効性を予測するための方法
|
|
WO2011121055A1
(en)
|
2010-03-31 |
2011-10-06 |
Topotarget A/S |
Pyridinyl derivatives comprising a cyanoguanidine or squaric acid moiety
|
|
MX347889B
(es)
|
2010-09-03 |
2017-05-17 |
Forma Tm Llc * |
Compuestos y composiciones novedosos para la inhibición de nampt.
|
|
WO2012031196A1
(en)
|
2010-09-03 |
2012-03-08 |
Forma Therapeutics, Inc. |
4- { [ ( pyridin- 3 - yl -methyl) aminocarbonyl] amino} benzene - sulfone derivatives as nampt inhibitors for therapy of diseases such as cancer
|
|
US9676721B2
(en)
|
2010-09-03 |
2017-06-13 |
Forma Tm, Llc |
Compounds and compositions for the inhibition of NAMPT
|
|
ES2622881T3
(es)
*
|
2010-09-29 |
2017-07-07 |
Intervet International B.V. |
Compuestos de N-heteroarilo
|
|
CN103347860A
(zh)
|
2010-11-15 |
2013-10-09 |
Abbvie公司 |
Nampt抑制剂
|
|
SG190819A1
(en)
|
2010-11-15 |
2013-07-31 |
Abbvie Inc |
Nampt and rock inhibitors
|
|
KR20140027366A
(ko)
|
2011-05-04 |
2014-03-06 |
포르마 티엠, 엘엘씨. |
Nampt의 억제를 위한 신규 화합물 및 조성물
|
|
US9555039B2
(en)
|
2011-05-09 |
2017-01-31 |
Forma Tm, Llc. |
Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (NAMPT)
|
|
UA114323C2
(uk)
|
2012-05-11 |
2017-05-25 |
Еббві Інк. |
Інгібітори nampt
|
|
CA2873075A1
(en)
|
2012-05-11 |
2013-07-14 |
Abbvie Inc. |
Nampt inhibitors
|
|
CN104271572A
(zh)
|
2012-05-11 |
2015-01-07 |
艾伯维公司 |
用作nampt抑制剂的噻唑羧酰胺衍生物
|
|
EP2847181A1
(en)
|
2012-05-11 |
2015-03-18 |
AbbVie Inc. |
Pyridazine and pyridine derivatives as nampt inhibitors
|
|
EP2925750A1
(en)
|
2012-11-29 |
2015-10-07 |
Karyopharm Therapeutics, Inc. |
Substituted 2,3-dihydrobenzofuranyl compounds and uses thereof
|
|
AU2014285019C1
(en)
|
2013-07-03 |
2019-05-02 |
Karyopharm Therapeutics Inc. |
Substituted benzofuranyl and benzoxazolyl compounds and uses thereof
|
|
WO2015042414A1
(en)
|
2013-09-20 |
2015-03-26 |
Karyopharm Therapeutics Inc. |
Multicyclic compounds and methods of using same
|
|
MX2018001979A
(es)
|
2015-08-18 |
2019-04-25 |
Karyopharm Therapeutics Inc |
(s,e) -3- (6-aminopiridin-3-il) -n- ( (5- (4- (3-fluoruro-3 metilpirrolidin-1-carbonil) fenil) -7- (4 fluorofenil) benzofuran-2-il)metil)acrilamida para el tratamiento del cancer.
|
|
WO2017117447A1
(en)
|
2015-12-31 |
2017-07-06 |
Karyopharm Therapeutics Inc. |
Multicyclic compounds and uses thereof
|
|
EP3528850A4
(en)
|
2016-10-18 |
2020-06-24 |
Seattle Genetics, Inc. |
Targeted delivery of nicotinamide adenine dinucleotide salvage pathway inhibitors
|
|
WO2018086703A1
(en)
|
2016-11-11 |
2018-05-17 |
Bayer Pharma Aktiengesellschaft |
Dihydropyridazinones substituted with phenylureas
|
|
EP3615081A1
(en)
|
2017-04-27 |
2020-03-04 |
Seattle Genetics, Inc. |
Quaternized nicotinamide adenine dinucleotide salvage pathway inhibitor conjugates
|
|
WO2019149637A1
(en)
|
2018-01-31 |
2019-08-08 |
Bayer Aktiengesellschaft |
Antibody drug conjugates (adcs) with nampt inhibitors
|
|
CN119775198A
(zh)
|
2018-05-04 |
2025-04-08 |
治疗方案股份有限公司 |
靶向癌症干细胞的癌症治疗
|
|
WO2021013693A1
(en)
|
2019-07-23 |
2021-01-28 |
Bayer Pharma Aktiengesellschaft |
Antibody drug conjugates (adcs) with nampt inhibitors
|
|
KR20220110744A
(ko)
|
2019-11-06 |
2022-08-09 |
레미디 플랜, 인크. |
암 줄기 세포를 표적화하는 암 치료
|
|
US20240376074A1
(en)
|
2021-05-13 |
2024-11-14 |
Remedy Plan, Inc. |
Nampt inhibitors and uses thereof
|